A Win For Leap Therapeutics, Inc.
Thu, Sep 16, 2021 at 05:30 PM
Leap Therapeutics, Inc. (LPTX:NASDAQ) soared at $2.53, representing a gain of 31.1%. On Wed, Sep 15, 2021, LPTX:NASDAQ touched a New 2-Week High of $1.93. The stock got featured on our News Catalysts scanner on Thu, Sep 16, 2021 at 03:08 AM in the 'BIOTECH' category. From Wed, Sep 01, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
About Leap Therapeutics, Inc. (LPTX:NASDAQ)
Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.
Top 10 Gainers:
- OPAD (OPAD:NYSE), 58.74%
- LIDR (LIDR:NASDAQ), 36.53%
- EEIQ (EEIQ:NASDAQ), 33.33%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 31.09%
- BROS (BROS:NYSE), 30.86%
- IRNT (IRNT:NYSE), 28.85%
- SigmaTron International, Inc. (SGMA:NASDAQ), 26.94%
- ARQQ (ARQQ:NASDAQ), 26.5%
- TMC (TMC:NASDAQ), 23.9%
- AUUD (AUUD:NASDAQ), 23.62%